| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9326779 | Gynecologic Oncology | 2005 | 6 Pages |
Abstract
Patients with persistent or recurrent high-risk gestational trophoblastic neoplasia who develop resistance to methotrexate-containing treatment protocols should be treated with drug combinations employing a platinum agent and etoposide with or without bleomycin or ifosfamide.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
John R. Lurain, Bahareh Nejad,